Ovarian	0	7	O
cancers	8	15	O
overexpress	16	27	O
the	28	31	O
antimicrobial	32	45	O
protein	46	53	O
hCAP	54	58	B-Gene_or_gene_product
-	58	59	I-Gene_or_gene_product
18	59	61	I-Gene_or_gene_product
and	62	65	O
its	66	69	O
derivative	70	80	O
LL	81	83	B-Gene_or_gene_product
-	83	84	I-Gene_or_gene_product
37	84	86	I-Gene_or_gene_product
increases	87	96	O
ovarian	97	104	B-Cell
cancer	105	111	I-Cell
cell	112	116	I-Cell
proliferation	117	130	O
and	131	134	O
invasion	135	143	O
.	143	144	O

The	146	149	O
role	150	154	O
of	155	157	O
the	158	161	O
pro	162	165	O
-	165	166	O
inflammatory	166	178	O
peptide	179	186	O
,	186	187	O
LL	188	190	B-Gene_or_gene_product
-	190	191	I-Gene_or_gene_product
37	191	193	I-Gene_or_gene_product
,	193	194	O
and	195	198	O
its	199	202	O
pro	203	206	O
-	206	207	O
form	207	211	O
,	211	212	O
human	213	218	B-Gene_or_gene_product
cationic	219	227	I-Gene_or_gene_product
antimicrobial	228	241	I-Gene_or_gene_product
protein	242	249	I-Gene_or_gene_product
18	250	252	I-Gene_or_gene_product
(	253	254	O
hCAP	254	258	B-Gene_or_gene_product
-	258	259	I-Gene_or_gene_product
18	259	261	I-Gene_or_gene_product
)	261	262	O
,	262	263	O
in	264	266	O
cancer	267	273	B-Pathological_formation
development	274	285	O
and	286	289	O
progression	290	301	O
is	302	304	O
poorly	305	311	O
understood	312	322	O
.	322	323	O

In	324	326	O
damaged	327	334	O
and	335	338	O
inflamed	339	347	O
tissue	348	354	B-Tissue
,	354	355	O
LL	356	358	B-Gene_or_gene_product
-	358	359	I-Gene_or_gene_product
37	359	361	I-Gene_or_gene_product
functions	362	371	O
as	372	374	O
a	375	376	O
chemoattractant	377	392	O
,	392	393	O
mitogen	394	401	O
and	402	405	O
pro	406	409	O
-	409	410	O
angiogenic	410	420	O
factor	421	427	O
suggesting	428	438	O
that	439	443	O
the	444	447	O
peptide	448	455	O
may	456	459	O
potentiate	460	470	O
tumor	471	476	B-Pathological_formation
progression	477	488	O
.	488	489	O

The	490	493	O
aim	494	497	O
of	498	500	O
this	501	505	O
study	506	511	O
was	512	515	O
to	516	518	O
characterize	519	531	O
the	532	535	O
distribution	536	548	O
of	549	551	O
hCAP	552	556	B-Gene_or_gene_product
-	556	557	I-Gene_or_gene_product
18	557	559	I-Gene_or_gene_product
/	559	560	O
LL	560	562	B-Gene_or_gene_product
-	562	563	I-Gene_or_gene_product
37	563	565	I-Gene_or_gene_product
in	566	568	O
normal	569	575	O
and	576	579	O
cancerous	580	589	O
ovarian	590	597	B-Tissue
tissue	598	604	I-Tissue
and	605	608	O
to	609	611	O
examine	612	619	O
the	620	623	O
effects	624	631	O
of	632	634	O
LL	635	637	B-Gene_or_gene_product
-	637	638	I-Gene_or_gene_product
37	638	640	I-Gene_or_gene_product
on	641	643	O
ovarian	644	651	B-Cell
cancer	652	658	I-Cell
cells	659	664	I-Cell
.	664	665	O

Expression	666	676	O
of	677	679	O
hCAP	680	684	B-Gene_or_gene_product
-	684	685	I-Gene_or_gene_product
18	685	687	I-Gene_or_gene_product
/	687	688	O
LL	688	690	B-Gene_or_gene_product
-	690	691	I-Gene_or_gene_product
37	691	693	I-Gene_or_gene_product
was	694	697	O
localized	698	707	O
to	708	710	O
immune	711	717	B-Cell
and	718	721	O
granulosa	722	731	B-Cell
cells	732	737	I-Cell
of	738	740	O
normal	741	747	B-Tissue
ovarian	748	755	I-Tissue
tissue	756	762	I-Tissue
.	762	763	O

By	764	766	O
contrast	767	775	O
,	775	776	O
ovarian	777	784	B-Pathological_formation
tumors	785	791	I-Pathological_formation
displayed	792	801	O
significantly	802	815	O
higher	816	822	O
levels	823	829	O
of	830	832	O
hCAP	833	837	B-Gene_or_gene_product
-	837	838	I-Gene_or_gene_product
18	838	840	I-Gene_or_gene_product
/	840	841	O
LL	841	843	B-Gene_or_gene_product
-	843	844	I-Gene_or_gene_product
37	844	846	I-Gene_or_gene_product
where	847	852	O
expression	853	863	O
was	864	867	O
observed	868	876	O
in	877	879	O
tumor	880	885	B-Cell
and	886	889	O
stromal	890	897	B-Cell
cells	898	903	I-Cell
.	903	904	O

Protein	905	912	O
expression	913	923	O
was	924	927	O
statistically	928	941	O
compared	942	950	O
to	951	953	O
the	954	957	O
degree	958	964	O
of	965	967	O
immune	968	974	B-Cell
cell	975	979	I-Cell
infiltration	980	992	O
and	993	996	O
microvessel	997	1008	B-Tissue
density	1009	1016	O
in	1017	1019	O
epithelial	1020	1030	B-Pathological_formation
-	1030	1031	I-Pathological_formation
derived	1031	1038	I-Pathological_formation
ovarian	1039	1046	I-Pathological_formation
tumors	1047	1053	I-Pathological_formation
and	1054	1057	O
a	1058	1059	O
significant	1060	1071	O
correlation	1072	1083	O
was	1084	1087	O
observed	1088	1096	O
for	1097	1100	O
both	1101	1105	O
.	1105	1106	O

It	1107	1109	O
was	1110	1113	O
demonstrated	1114	1126	O
that	1127	1131	O
ovarian	1132	1139	B-Organism_substance
tumor	1140	1145	I-Organism_substance
tissue	1146	1152	I-Organism_substance
lysates	1153	1160	I-Organism_substance
and	1161	1164	O
ovarian	1165	1172	B-Cell
cancer	1173	1179	I-Cell
cell	1180	1184	I-Cell
lines	1185	1190	I-Cell
express	1191	1198	O
hCAP	1199	1203	B-Gene_or_gene_product
-	1203	1204	I-Gene_or_gene_product
18	1204	1206	I-Gene_or_gene_product
/	1206	1207	O
LL	1207	1209	B-Gene_or_gene_product
-	1209	1210	I-Gene_or_gene_product
37	1210	1212	I-Gene_or_gene_product
.	1212	1213	O

Treatment	1214	1223	O
of	1224	1226	O
ovarian	1227	1234	B-Cell
cancer	1235	1241	I-Cell
cell	1242	1246	I-Cell
lines	1247	1252	I-Cell
with	1253	1257	O
recombinant	1258	1269	O
LL	1270	1272	B-Gene_or_gene_product
-	1272	1273	I-Gene_or_gene_product
37	1273	1275	I-Gene_or_gene_product
stimulated	1276	1286	O
proliferation	1287	1300	O
,	1300	1301	O
chemotaxis	1302	1312	O
,	1312	1313	O
invasion	1314	1322	O
and	1323	1326	O
matrix	1327	1333	B-Gene_or_gene_product
metalloproteinase	1334	1351	I-Gene_or_gene_product
expression	1352	1362	O
.	1362	1363	O

These	1364	1369	O
data	1370	1374	O
demonstrate	1375	1386	O
for	1387	1390	O
the	1391	1394	O
first	1395	1400	O
time	1401	1405	O
that	1406	1410	O
hCAP	1411	1415	B-Gene_or_gene_product
-	1415	1416	I-Gene_or_gene_product
18	1416	1418	I-Gene_or_gene_product
/	1418	1419	O
LL	1419	1421	B-Gene_or_gene_product
-	1421	1422	I-Gene_or_gene_product
37	1422	1424	I-Gene_or_gene_product
is	1425	1427	O
significantly	1428	1441	O
overexpressed	1442	1455	O
in	1456	1458	O
ovarian	1459	1466	B-Pathological_formation
tumors	1467	1473	I-Pathological_formation
and	1474	1477	O
suggest	1478	1485	O
LL	1486	1488	B-Gene_or_gene_product
-	1488	1489	I-Gene_or_gene_product
37	1489	1491	I-Gene_or_gene_product
may	1492	1495	O
contribute	1496	1506	O
to	1507	1509	O
ovarian	1510	1517	O
tumorigenesis	1518	1531	O
through	1532	1539	O
direct	1540	1546	O
stimulation	1547	1558	O
of	1559	1561	O
tumor	1562	1567	B-Cell
cells	1568	1573	I-Cell
,	1573	1574	O
initiation	1575	1585	O
of	1586	1588	O
angiogenesis	1589	1601	O
and	1602	1605	O
recruitment	1606	1617	O
of	1618	1620	O
immune	1621	1627	B-Cell
cells	1628	1633	I-Cell
.	1633	1634	O

These	1635	1640	O
data	1641	1645	O
provide	1646	1653	O
further	1654	1661	O
evidence	1662	1670	O
of	1671	1673	O
the	1674	1677	O
existing	1678	1686	O
relationship	1687	1699	O
between	1700	1707	O
pro	1708	1711	O
-	1711	1712	O
inflammatory	1712	1724	O
molecules	1725	1734	O
and	1735	1738	O
ovarian	1739	1746	B-Pathological_formation
cancer	1747	1753	I-Pathological_formation
progression	1754	1765	O
.	1765	1766	O

